FDA extends DTC guidance comment period
FDA reopens comment period for draft guidances on direct-to-consumer advertising until Aug. 10. "We got comments that folks wanted more time to do DTC research, complete DTC research and also more time to provide comments," Ad Division Director Tom Abrams said during a DIA audioconference May 27. The agency also plans to conduct its own research on the content and format of the brief summary. FDA released the DTC guidances Feb. 4 (1"The Pink Sheet" Feb. 9, 2004, p. 3)...
You may also be interested in...
FDA's publication of three draft guidances on direct-to-consumer advertising is unlikely to relieve pressure on the agency to explain its approach to enforcement actions against drug manufacturers that repeatedly run false and misleading promotions
The EU is pulling out all the stops to have the one-year delay to the MDR adopted before it is too late, and a crucial vote will take place on 16 April.
As US cases set to reach half a million, FDA gives green light to blood plasma trials to help meet urgent need for therapies.